Frieder Fuchs

963 total citations · 1 hit paper
31 papers, 659 citations indexed

About

Frieder Fuchs is a scholar working on Epidemiology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, Frieder Fuchs has authored 31 papers receiving a total of 659 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 13 papers in Infectious Diseases and 11 papers in Molecular Medicine. Recurrent topics in Frieder Fuchs's work include Antibiotic Resistance in Bacteria (11 papers), Antifungal resistance and susceptibility (9 papers) and Urinary Tract Infections Management (7 papers). Frieder Fuchs is often cited by papers focused on Antibiotic Resistance in Bacteria (11 papers), Antifungal resistance and susceptibility (9 papers) and Urinary Tract Infections Management (7 papers). Frieder Fuchs collaborates with scholars based in Germany, Spain and United States. Frieder Fuchs's co-authors include Axel Hamprecht, Philipp Koehler, Oliver A. Cornely, Jan Rybniker, Alexander Shimabukuro‐Vornhagen, Bernd W. Böttiger, Dennis A. Eichenauer, Matthias Kochanek, Thorsten Persigehl and Fabian Dusse and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology.

In The Last Decade

Frieder Fuchs

27 papers receiving 648 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

COVID‐19 associated pulmonary aspergillosis

2020 401 citations Philipp Koehler, Oliver A. Cornely et al. Mycoses profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frieder Fuchs Germany	11	439	320	102	84	83	31	659
José Luís López-Hontangas Spain	12	366 0.8×	383 1.2×	81 0.8×	80 1.0×	49 0.6×	38	681
Elia Gómez G. de la Pedrosa Spain	11	308 0.7×	279 0.9×	68 0.7×	96 1.1×	42 0.5×	22	500
Laura Magnasco Italy	14	491 1.1×	281 0.9×	51 0.5×	61 0.7×	39 0.5×	35	622
Toyoko Oguri Japan	15	349 0.8×	229 0.7×	143 1.4×	115 1.4×	95 1.1×	85	626
Chun-Eng Liu Taiwan	10	198 0.5×	199 0.6×	110 1.1×	194 2.3×	75 0.9×	13	586
Canan Külah Türkiye	16	185 0.4×	174 0.5×	112 1.1×	220 2.6×	84 1.0×	37	582
Zayre Erturan Türkiye	16	383 0.9×	317 1.0×	144 1.4×	64 0.8×	30 0.4×	49	621
Mohammadreza Salehi Iran	11	373 0.8×	289 0.9×	60 0.6×	23 0.3×	40 0.5×	75	565
Alper Tünger Türkiye	13	122 0.3×	203 0.6×	48 0.5×	107 1.3×	61 0.7×	41	437
Anupop Jitmuang Thailand	12	145 0.3×	217 0.7×	45 0.4×	128 1.5×	76 0.9×	33	428

Countries citing papers authored by Frieder Fuchs

Since Specialization

Citations

This map shows the geographic impact of Frieder Fuchs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frieder Fuchs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frieder Fuchs more than expected).

Fields of papers citing papers by Frieder Fuchs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frieder Fuchs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frieder Fuchs. The network helps show where Frieder Fuchs may publish in the future.

Co-authorship network of co-authors of Frieder Fuchs

This figure shows the co-authorship network connecting the top 25 collaborators of Frieder Fuchs. A scholar is included among the top collaborators of Frieder Fuchs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frieder Fuchs. Frieder Fuchs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fuchs, Frieder, et al.. (2025). Cross-Sectional Assessment on Carbapenem-Resistant Gram-Negative Bacteria Isolated from Patients in Moldova. Microorganisms. 13(2). 421–421. 1 indexed citations

Lebreton, François, Niels Pfennigwerth, Brendan T. Jones, et al.. (2025). High genetic relatedness between multidrug resistant bacteria before and after the 2022 invasion of Ukraine. Genome Medicine. 17(1). 74–74.

Fuchs, Frieder, et al.. (2024). Coexistence of seven different carbapenemase producers in a single hospital admission screening confirmed by whole-genome sequencing. Journal of Global Antimicrobial Resistance. 39. 184–188. 5 indexed citations

Balczun, Carsten, et al.. (2024). A Case of Pseudomonas straminea Blood Stream Infection in an Elderly Woman with Cellulitis. Infectious Disease Reports. 16(4). 699–706.

Rodríguez-Expósito, Rubén L., Inés Sifaoui, María Reyes-Batllé, et al.. (2023). Induction of Programmed Cell Death in Acanthamoeba culbertsoni by the Repurposed Compound Nitroxoline. Antioxidants. 12(12). 2081–2081. 8 indexed citations

Li, Yuchan, Jochen Gaedcke, Cornelis F.M. Sier, et al.. (2023). Urokinase-Type Plasminogen Activator Receptor (uPAR) Cooperates with Mutated KRAS in Regulating Cellular Plasticity and Gemcitabine Response in Pancreatic Adenocarcinomas. Cancers. 15(5). 1587–1587. 9 indexed citations

Rybniker, Jan, et al.. (2023). Activity of the old antimicrobial nitroxoline against Mycobacterium abscessus complex isolates. Journal of Global Antimicrobial Resistance. 33. 1–4. 3 indexed citations

Fuchs, Frieder, et al.. (2023). Repurposing of Nitroxoline as an Alternative Primary Amoebic Meningoencephalitis Treatment. Antibiotics. 12(8). 1280–1280. 4 indexed citations

Hamprecht, Axel, et al.. (2023). Proteus mirabilis – analysis of a concealed source of carbapenemases and development of a diagnostic algorithm for detection. Clinical Microbiology and Infection. 29(9). 1198.e1–1198.e6. 12 indexed citations

10.

Fuchs, Frieder, et al.. (2023). Susceptibility of Aerococcus urinae and Aerococcus sanguinicola to Standard Antibiotics and to Nitroxoline. Microbiology Spectrum. 11(2). e0276322–e0276322. 5 indexed citations

11.

Fuchs, Frieder, et al.. (2022). Usefulness of screening for Candida auris colonisation in international patients admitted to a large university hospital. Mycoses. 66(2). 138–143. 7 indexed citations

12.

Knoll, Miriam A., Nina Lackner, Hanno Ulmer, et al.. (2022). Multiple colony antifungal susceptibility testing detects polyresistance in clinical Candida cultures: a European Confederation of Medical Mycology excellence centers study. Clinical Microbiology and Infection. 28(9). 1288.e1–1288.e7. 7 indexed citations

13.

Kaasch, Achim J., Frieder Fuchs, Hong Bin Kim, et al.. (2022). Impact of neutropenia on clinical manifestations and outcome of Staphylococcus aureus bloodstream infection: a propensity score-based overlap weight analysis in two large, prospectively evaluated cohorts. Clinical Microbiology and Infection. 28(8). 1149.e1–1149.e9. 4 indexed citations

14.

Rybniker, Jan, et al.. (2022). In vitro Activity of Repurposed Nitroxoline Against Clinically Isolated Mycobacteria Including Multidrug-Resistant Mycobacterium tuberculosis. Frontiers in Pharmacology. 13. 906097–906097. 8 indexed citations

15.

Fuchs, Frieder, et al.. (2022). In vitro activity of mecillinam, temocillin and nitroxoline against MDR Enterobacterales. JAC-Antimicrobial Resistance. 4(3). dlac059–dlac059. 8 indexed citations

16.

Steenwyk, Jacob L., Matthew E. Mead, Patrícia Alves de Castro, et al.. (2021). Genomic and Phenotypic Analysis of COVID-19-Associated Pulmonary Aspergillosis Isolates of Aspergillus fumigatus. Microbiology Spectrum. 9(1). e0001021–e0001021. 32 indexed citations

17.

Fuchs, Frieder, Herbert Hof, Sandra Hofmann, et al.. (2021). Antifungal activity of nitroxoline against Candida auris isolates. Clinical Microbiology and Infection. 27(11). 1697.e7–1697.e10. 29 indexed citations

18.

Fuchs, Frieder, et al.. (2021). Susceptibility of Clinical Enterobacterales Isolates With Common and Rare Carbapenemases to Mecillinam. Frontiers in Microbiology. 11. 627267–627267. 15 indexed citations

19.

Koehler, Philipp, Sibylle C. Mellinghoff, Jannik Stemler, et al.. (2019). Quantifying guideline adherence in mucormycosis management using the EQUAL score. Mycoses. 63(4). 343–351. 11 indexed citations

20.

Fuchs, Frieder. (1954). [Aids in medical thesis writing].. PubMed. 116(9). 361–2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact